From the literature, it is proposed that ClC-3 and MMP-2 form a protein complex that is targeted by the CTX-peptide, and this action is thought to inhibit glioma cell migration and invasion through the induction of endocytosis of the MMP-2/ClC-3 protein complex [38,48,124]. This evidence concerns the gene CLCN3 and central nervous system cancer.